| scholarly article | Q13442814 |
| P50 | author | Markus Heilig | Q42632514 |
| P2093 | author name string | Rose-Marie Karlsson | |
| Andrew Holmes | |||
| Kohichi Tanaka | |||
| P2860 | cites work | Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial | Q28244389 |
| Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia | Q28274064 | ||
| Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats | Q28280906 | ||
| Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats | Q28297687 | ||
| Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice | Q28508015 | ||
| Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence | Q29618819 | ||
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| Pharmacology and functions of metabotropic glutamate receptors | Q29619150 | ||
| Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate | Q29620128 | ||
| Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. | Q33186255 | ||
| Glutamate and schizophrenia: beyond the dopamine hypothesis | Q33996803 | ||
| NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons | Q34197064 | ||
| NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex | Q34376159 | ||
| Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. | Q35990236 | ||
| Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? | Q36517227 | ||
| Modeling madness in mice: one piece at a time | Q36610374 | ||
| Glutamate and monoamine transporters: new visions of form and function | Q36825439 | ||
| Glutamate transporters: confining runaway excitation by shaping synaptic transmission | Q36995107 | ||
| Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS. | Q40117295 | ||
| Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat. | Q42171479 | ||
| Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors | Q42628411 | ||
| Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. | Q48273349 | ||
| Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. | Q51536942 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | haloperidol | Q251347 |
| P304 | page(s) | 810-814 | |
| P577 | publication date | 2008-06-12 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist | |
| P478 | volume | 64 |
| Q56355639 | A Glutamate Transporter EAAT1 Gene Variant Influences Amygdala Functional Connectivity in Bipolar Disorder |
| Q35749730 | Abnormal Astrocytosis in the Basal Ganglia Pathway of Git1(-/-) Mice |
| Q36609289 | Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia |
| Q35402761 | Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice |
| Q39250923 | Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma |
| Q30465586 | Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia |
| Q59128381 | Astrocytic Regulation of Glutamate Transmission in Schizophrenia |
| Q48027529 | Astroglia, Glutamatergic Transmission and Psychiatric Diseases |
| Q27310784 | Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice |
| Q39920030 | Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli |
| Q30090165 | Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4. |
| Q35791075 | Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons? |
| Q42154902 | Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia |
| Q64063761 | Control of Long-Term Plasticity by Glutamate Transporters |
| Q38835953 | Disentangling the Role of Astrocytes in Alcohol Use Disorder |
| Q48572492 | Down-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by the Kinases SPAK and OSR1. |
| Q37112450 | Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice |
| Q30466299 | Effects of genetic deletion of the Kv4.2 voltage-gated potassium channel on murine anxiety-, fear- and stress-related behaviors |
| Q37159920 | Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress |
| Q90473578 | General Pathophysiology of Astroglia |
| Q30541844 | GluN2B in corticostriatal circuits governs choice learning and choice shifting. |
| Q51748790 | Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction. |
| Q55505650 | Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders. |
| Q34223138 | Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior |
| Q26824012 | Glutamatergic targets for new alcohol medications |
| Q30483032 | Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. |
| Q48123221 | Hippocampal glutamate level and glutamate aspartate transporter (GLAST) are up-regulated in senior rat associated with isoflurane-induced spatial learning/memory impairment |
| Q34184026 | Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study |
| Q64450655 | Loss of cerebellar glutamate transporters EAAT4 and GLAST differentially affects the spontaneous firing pattern and survival of Purkinje cells |
| Q64098548 | Mice lacking Casp1, Ifngr and Nos2 genes exhibit altered depressive- and anxiety-like behaviour, and gut microbiome composition |
| Q30454958 | Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery |
| Q30476813 | Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects |
| Q38459199 | Molecular approaches for manipulating astrocytic signaling in vivo. |
| Q34181201 | New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats |
| Q34273724 | Overstimulation of NMDA receptors impairs early brain development in vivo |
| Q35374971 | Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice |
| Q34125605 | Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia |
| Q30451627 | Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST. |
| Q37495425 | SLC1 glutamate transporters |
| Q26825021 | Stress-induced deficits in cognition and emotionality: a role of glutamate |
| Q54323354 | Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness. |
| Q38069972 | Systems biology, bioinformatics, and biomarkers in neuropsychiatry |
| Q48709460 | Transcriptional regulation of the GLAST/EAAT-1 gene in rat and man. |
| Q38589482 | Translational potential of astrocytes in brain disorders |
| Q42968242 | Update on the neurobiology of schizophrenia: a role for extracellular microdomains. |
Search more.